Back

Intermittent scheduled low-dose levosimendan infusions improves event-free survival in advanced chronic heart failure: a propensity score matching analysis.

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 6 - Advanced heart failure Advance heart failure HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Patrick Yerly

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

14 More presentations in this session

Presentation thumbnail
Clinical outcomes of temporary mechanical circulatory support as a bridge to heart transplantation in Spain: a nationwide registry.
Doctor E. Barge Caballero (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Heart transplantation in patients with high immunological risk is safe when performed with a specific desensitization program.
Doctor G. Coutance (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Incidence and prognostic impact of adverse clinical events associated to mechanical circulatory support in patients bridged to transplantation on temporary devices: a nationwide Spanish registry.
Doctor E. Barge Caballero (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Hypochloremia in advanced heart failure: association with hemodynamics and prognosis
Doctor H. Lim (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
What is the best hemodynamic predictor of survival in patients with advanced systolic heart failure ?
Doctor P. de Groote (Lille, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 6 - Advanced heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources